268 related articles for article (PubMed ID: 18353766)
1. Quantitative proteomics of a presymptomatic A53T alpha-synuclein Drosophila model of Parkinson disease.
Xun Z; Sowell RA; Kaufman TC; Clemmer DE
Mol Cell Proteomics; 2008 Jul; 7(7):1191-203. PubMed ID: 18353766
[TBL] [Abstract][Full Text] [Related]
2. Proteome response to the panneural expression of human wild-type alpha-synuclein: a Drosophila model of Parkinson's disease.
Xun Z; Kaufman TC; Clemmer DE
J Proteome Res; 2008 Sep; 7(9):3911-21. PubMed ID: 18683964
[TBL] [Abstract][Full Text] [Related]
3. Lifetime proteomic profiling of an A30P alpha-synuclein Drosophila model of Parkinson's disease.
Xun Z; Sowell RA; Kaufman TC; Clemmer DE
J Proteome Res; 2007 Sep; 6(9):3729-38. PubMed ID: 17683129
[TBL] [Abstract][Full Text] [Related]
4. Differential interaction between iron and mutant alpha-synuclein causes distinctive Parkinsonian phenotypes in Drosophila.
Zhu ZJ; Wu KC; Yung WH; Qian ZM; Ke Y
Biochim Biophys Acta; 2016 Apr; 1862(4):518-525. PubMed ID: 26769358
[TBL] [Abstract][Full Text] [Related]
5. Protein expression in a Drosophila model of Parkinson's disease.
Xun Z; Sowell RA; Kaufman TC; Clemmer DE
J Proteome Res; 2007 Jan; 6(1):348-57. PubMed ID: 17203978
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of wild-type and A53T mutant isoform of alpha-synuclein on the mitochondrial proteome of differentiated SH-SY5Y cells.
Pennington K; Peng J; Hung CC; Banks RE; Robinson PA
J Proteome Res; 2010 May; 9(5):2390-401. PubMed ID: 20334438
[TBL] [Abstract][Full Text] [Related]
7. Stable isotope labeling and label-free proteomics of Drosophila parkin null mutants.
Xun Z; Kaufman TC; Clemmer DE
J Proteome Res; 2009 Oct; 8(10):4500-10. PubMed ID: 19705877
[TBL] [Abstract][Full Text] [Related]
8. Quantitative proteomics in A30P*A53T α-synuclein transgenic mice reveals upregulation of Sel1l.
Yan J; Zhang P; Jiao F; Wang Q; He F; Zhang Q; Zhang Z; Lv Z; Peng X; Cai H; Tian B
PLoS One; 2017; 12(8):e0182092. PubMed ID: 28771510
[TBL] [Abstract][Full Text] [Related]
9. Intracerebral Administration of a Ligand-ASO Conjugate Selectively Reduces α-Synuclein Accumulation in Monoamine Neurons of Double Mutant Human A30P*A53T*α-Synuclein Transgenic Mice.
Pavia-Collado R; Cóppola-Segovia V; Miquel-Rio L; Alarcón-Aris D; Rodríguez-Aller R; Torres-López M; Paz V; Ruiz-Bronchal E; Campa L; Artigas F; Montefeltro A; Revilla R; Bortolozzi A
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805843
[TBL] [Abstract][Full Text] [Related]
10. Endoplasmic reticulum stress and mitochondrial cell death pathways mediate A53T mutant alpha-synuclein-induced toxicity.
Smith WW; Jiang H; Pei Z; Tanaka Y; Morita H; Sawa A; Dawson VL; Dawson TM; Ross CA
Hum Mol Genet; 2005 Dec; 14(24):3801-11. PubMed ID: 16239241
[TBL] [Abstract][Full Text] [Related]
11. Complement and Coagulation Cascades are Potentially Involved in Dopaminergic Neurodegeneration in α-Synuclein-Based Mouse Models of Parkinson's Disease.
Ma SX; Seo BA; Kim D; Xiong Y; Kwon SH; Brahmachari S; Kim S; Kam TI; Nirujogi RS; Kwon SH; Dawson VL; Dawson TM; Pandey A; Na CH; Ko HS
J Proteome Res; 2021 Jul; 20(7):3428-3443. PubMed ID: 34061533
[TBL] [Abstract][Full Text] [Related]
12. E46K mutant α-synuclein is more degradation resistant and exhibits greater toxic effects than wild-type α-synuclein in Drosophila models of Parkinson's disease.
Sakai R; Suzuki M; Ueyama M; Takeuchi T; Minakawa EN; Hayakawa H; Baba K; Mochizuki H; Nagai Y
PLoS One; 2019; 14(6):e0218261. PubMed ID: 31242217
[TBL] [Abstract][Full Text] [Related]
13. The mitochondrial chaperone protein TRAP1 mitigates α-Synuclein toxicity.
Butler EK; Voigt A; Lutz AK; Toegel JP; Gerhardt E; Karsten P; Falkenburger B; Reinartz A; Winklhofer KF; Schulz JB
PLoS Genet; 2012 Feb; 8(2):e1002488. PubMed ID: 22319455
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA expressing profiles in A53T mutant alpha-synuclein transgenic mice and Parkinsonian.
Mo M; Xiao Y; Huang S; Cen L; Chen X; Zhang L; Luo Q; Li S; Yang X; Lin X; Xu P
Oncotarget; 2017 Jan; 8(1):15-28. PubMed ID: 27965467
[TBL] [Abstract][Full Text] [Related]
15. A new Drosophila model to study the interaction between genetic and environmental factors in Parkinson's disease.
Varga SJ; Qi C; Podolsky E; Lee D
Brain Res; 2014 Oct; 1583():277-86. PubMed ID: 25130663
[TBL] [Abstract][Full Text] [Related]
16. Reduction of the α-synuclein expression promotes slowing down early neuropathology development in the
Golomidov IM; Latypova EM; Ryabova EV; Bolshakova OI; Komissarov AE; Sarantseva SV
J Neurogenet; 2022 Mar; 36(1):1-10. PubMed ID: 35467466
[TBL] [Abstract][Full Text] [Related]
17. Quantitative Phosphoproteomic Analysis in Alpha-Synuclein Transgenic Mice Reveals the Involvement of Aberrant p25/Cdk5 Signaling in Early-stage Parkinson's Disease.
He F; Qi G; Zhang Q; Cai H; Li T; Li M; Zhang Q; Chen J; Ming J; Tian B; Zhang P
Cell Mol Neurobiol; 2020 Aug; 40(6):897-909. PubMed ID: 32016637
[TBL] [Abstract][Full Text] [Related]
18. Genomic DNA levels of mutant alpha-synuclein correlate with non-motor symptoms in an A53T Parkinson's disease mouse model.
Wang W; Song N; Jia F; Tang T; Bao W; Zuo C; Xie J; Jiang H
Neurochem Int; 2018 Mar; 114():71-79. PubMed ID: 29355568
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial associated metabolic proteins are selectively oxidized in A30P alpha-synuclein transgenic mice--a model of familial Parkinson's disease.
Poon HF; Frasier M; Shreve N; Calabrese V; Wolozin B; Butterfield DA
Neurobiol Dis; 2005 Apr; 18(3):492-8. PubMed ID: 15755676
[TBL] [Abstract][Full Text] [Related]
20. Cyclin-G-associated kinase modifies α-synuclein expression levels and toxicity in Parkinson's disease: results from the GenePD Study.
Dumitriu A; Pacheco CD; Wilk JB; Strathearn KE; Latourelle JC; Goldwurm S; Pezzoli G; Rochet JC; Lindquist S; Myers RH
Hum Mol Genet; 2011 Apr; 20(8):1478-87. PubMed ID: 21258085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
